Cargando…

Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait

Detalles Bibliográficos
Autores principales:	Pirola, Carlos J., Sookoian, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597216/ https://www.ncbi.nlm.nih.gov/pubmed/35989091 http://dx.doi.org/10.3350/cmh.2022.0208

Ejemplares similares

Repurposing drugs to target nonalcoholic steatohepatitis
por: Sookoian, Silvia, et al.
Publicado: (2019)

Heat Shock Protein 27 is down-regulated in Ballooned Hepatocytes of Patients with Nonalcoholic Steatohepatitis (NASH)
por: Sookoian, Silvia, et al.
Publicado: (2016)

Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
por: Pirola, Carlos Jose, et al.
Publicado: (2021)

The gold complex auranofin: new perspectives for cancer therapy
por: Abdalbari, Farah H., et al.
Publicado: (2021)

Genetic predisposition in nonalcoholic fatty liver disease
por: Sookoian, Silvia, et al.
Publicado: (2017)

Personalized medicine in nonalcoholic fatty liver disease
por: Pirola, Carlos J., et al.
Publicado: (2022)

The lipidome in nonalcoholic fatty liver disease: actionable targets
por: Pirola, Carlos J., et al.
Publicado: (2021)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

Systems Biology Elucidates Common Pathogenic Mechanisms between Nonalcoholic and Alcoholic-Fatty Liver Disease
por: Sookoian, Silvia, et al.
Publicado: (2013)

Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
por: Sookoian, Silvia, et al.
Publicado: (2020)

Metastasis‐associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune‐mediated liver damage
por: Sookoian, Silvia, et al.
Publicado: (2018)

A Rare Nonsense Mutation in the Glucokinase Regulator Gene Is Associated With a Rapidly Progressive Clinical Form of Nonalcoholic Steatohepatitis
por: Pirola, Carlos J., et al.
Publicado: (2018)

Auranofin: Repurposing an Old Drug for a Golden New Age
por: Roder, Christine, et al.
Publicado: (2015)

Repurposing Auranofin, an Anti-Rheumatic Gold Compound, to Treat Acne Vulgaris by Targeting the NLRP3 Inflammasome
por: Yang, Gabsik, et al.
Publicado: (2020)

Specifcations d'un dispositif de mesures optiques
por: Lohmann, KD
Publicado: (1969)

Repurposing Pirfenidone for Nonalcoholic Steatohepatitis-related Cirrhosis: A Case Series
por: Philips, Cyriac Abby, et al.
Publicado: (2020)

Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018)

Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis
por: Bulman, Christina A., et al.
Publicado: (2015)

The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD
por: Vilar-Gomez, Eduardo, et al.
Publicado: (2021)

Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease
por: Sookoian, Silvia, et al.
Publicado: (2017)

Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System
por: May, Holly C., et al.
Publicado: (2018)

Meta-analysis of the influence of TM6SF2 E167K variant on Plasma Concentration of Aminotransferases across different Populations and Diverse Liver Phenotypes
por: Sookoian, Silvia, et al.
Publicado: (2016)

Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis
por: Pirola, Carlos J, et al.
Publicado: (2020)

Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis
por: Pirola, Carlos J., et al.
Publicado: (2020)

COVID-19 and ACE2 in the Liver and Gastrointestinal Tract: Putative Biological Explanations of Sexual Dimorphism
por: Pirola, Carlos J., et al.
Publicado: (2020)

SARS-CoV-2 targets the liver and manipulates glucose metabolism
por: Pirola, Carlos J., et al.
Publicado: (2023)

Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
por: Sookoian, Silvia, et al.
Publicado: (2023)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Repurposing of auranofin and honokiol as antifungals against Scedosporium species and the related fungus Lomentospora prolificans
por: Yaakoub, Hajar, et al.
Publicado: (2021)

Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against C. albicans
por: Lin, Jiaying, et al.
Publicado: (2022)

Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections
por: Feng, Liwen, et al.
Publicado: (2020)

Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins
por: Pirola, Carlos J., et al.
Publicado: (2015)

Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma
por: Wang, Jeffrey, et al.
Publicado: (2019)

Antiproliferative Properties of a Few Auranofin-Related Gold(I) and Silver(I) Complexes in Leukemia Cells and their Interferences with the Ubiquitin Proteasome System
por: Cirri, Damiano, et al.
Publicado: (2020)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
por: Noureddin, Mazen, et al.
Publicado: (2019)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ligsmonv09flb86bsa6lfl62re